TREHU ELIZABETH (Chief Medical Officer) sold 8.2% of their position (9.29K shares) of JOUNCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $10.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/11/2023ACC: 0001640455-23-000011
Officer· Chief Medical Officer
Since Aug 2018
-9.29K
Net shares
Net seller
$10.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
9.29K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−4.16K
Price / share
$1.10
Trade value
$4.57K
% of position
3.7%
1/9/2023
112.70K→108.54K
Common Stock
Direct
Shares
−5.13K
Price / share
$1.12
Trade value
$5.74K
% of position
4.7%
1/10/2023
108.54K→103.42K
Total
Net shares
−9.29K
Net value
-$10.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/9/2023 | S · Sale | −4.16K | $1.10 | $4.57K | 3.7% | 112.70K | 108.54K |
| Common Stock Direct | 1/10/2023 | S · Sale | −5.13K | $1.12 | $5.74K | 4.7% | 108.54K | 103.42K |
| Total | −9.29K | -$10.32K | ||||||
Derivative Transactions0
No derivative transactions reported